Renalytix AI plc (RENX) - Net Assets

Latest as of December 2024: GBX-1.37 Million GBX ≈ $-166.57 USD

Based on the latest financial reports, Renalytix AI plc (RENX) has net assets worth GBX-1.37 Million GBX (≈ $-166.57 USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX11.44 Million ≈ $1.39K USD) and total liabilities (GBX12.81 Million ≈ $1.56K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Renalytix AI plc to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX-1.37 Million
% of Total Assets -11.97%
Annual Growth Rate N/A
5-Year Change -116.22%
10-Year Change -100.04%
Growth Volatility 32321.74

Renalytix AI plc - Net Assets Trend (2012–2025)

This chart illustrates how Renalytix AI plc's net assets have evolved over time, based on quarterly financial data. Also explore Renalytix AI plc (RENX) total assets for the complete picture of this company's asset base.

Annual Net Assets for Renalytix AI plc (2012–2025)

The table below shows the annual net assets of Renalytix AI plc from 2012 to 2025. For live valuation and market cap data, see Renalytix AI plc market capitalisation.

Year Net Assets Change
2025-06-30 GBX-7.00 Million
≈ $-851.70		 +10.87%
2024-06-30 GBX-7.85 Million
≈ $-955.60		 -100.04%
2023-12-31 GBX20.76 Billion
≈ $2.53 Million		 +112417.61%
2023-06-30 GBX18.45 Million
≈ $2.25K		 -57.25%
2022-06-30 GBX43.17 Million
≈ $5.25K		 -54.61%
2021-06-30 GBX95.10 Million
≈ $11.57K		 +164.45%
2020-06-30 GBX35.96 Million
≈ $4.38K		 +27.67%
2019-06-30 GBX28.17 Million
≈ $3.43K		 +300100.00%
2018-06-30 GBX-9.39K
≈ $-1.14		 -100.00%
2016-12-31 GBX17.87 Billion
≈ $2.17 Million		 +2.32%
2015-12-31 GBX17.47 Billion
≈ $2.13 Million		 +1.17%
2014-12-31 GBX17.26 Billion
≈ $2.10 Million		 -15.38%
2013-12-31 GBX20.40 Billion
≈ $2.48 Million		 -2.98%
2012-12-31 GBX21.03 Billion
≈ $2.56 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Renalytix AI plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 100.6% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock GBX1.10 Million %
Other Components GBX157.00 Million %
Total Equity GBX-7.00 Million 100.00%

Renalytix AI plc Competitors by Market Cap

The table below lists competitors of Renalytix AI plc ranked by their market capitalization.

Company Market Cap
Global Partner Acq Corp
NASDAQ:GPACU
 $96.36K
Landore Resources Plc
LSE:LND
 $97.16K
OCA Acquisition Corp
NASDAQ:OCAXU
 $98.60K
TAURUS GOLD CORP.
F:W1N
 $98.90K
DOLPHIN DRILL. A.S. NK 10
F:L33
 $95.54K
Green Leaf Innovations Inc.
NASDAQ:GRLFD
 $95.41K
G2Power Co. Ltd.
KQ:388050
 $94.81K
ANGLE plc
LSE:AGL
 $94.18K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Renalytix AI plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -7,854,000 to -7,000,000, a change of 854,000.
  • Net loss of 20,400,000 reduced equity.
  • New share issuances of 19,500,000 increased equity.
  • Other comprehensive income increased equity by 1,442,999.
  • Other factors increased equity by 311,001.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX-20.40 Million -291.43%
Share Issuances GBX19.50 Million +278.57%
Other Comprehensive Income GBX1.44 Million +20.61%
Other Changes GBX311.00K +4.44%
Total Change GBX- %

Book Value vs Market Value Analysis

This analysis compares Renalytix AI plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 GBX9.70 GBX1.80 x
2013-12-31 GBX9.87 GBX1.80 x
2014-12-31 GBX8.82 GBX1.80 x
2015-12-31 GBX8.79 GBX1.80 x
2016-12-31 GBX8.73 GBX1.80 x
2018-06-30 GBX0.00 GBX1.80 x
2019-06-30 GBX0.66 GBX1.80 x
2020-06-30 GBX0.61 GBX1.80 x
2021-06-30 GBX1.33 GBX1.80 x
2022-06-30 GBX0.41 GBX1.80 x
2023-06-30 GBX0.08 GBX1.80 x
2023-12-31 GBX186.10 GBX1.80 x
2024-06-30 GBX-0.07 GBX1.80 x
2025-06-30 GBX-0.07 GBX1.80 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Renalytix AI plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -680.00%
  • • Asset Turnover: 0.49x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-62.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 20.37% 8.51% 1.11x 2.15x GBX2.93 Billion
2013 23.11% 9.72% 1.09x 2.17x GBX3.78 Billion
2014 24.57% 10.68% 1.01x 2.28x GBX3.71 Billion
2015 21.25% 9.21% 1.02x 2.26x GBX2.82 Billion
2016 21.91% 9.83% 0.93x 2.38x GBX2.97 Billion
2018 0.00% 0.00% 0.00x 0.00x GBX-1.25 Million
2019 -150.18% 0.00% 0.00x 1.03x GBX-45.12 Million
2020 -27.37% -0.02% 1411.84x 1.15x GBX-13.44 Million
2021 -36.51% -2328.97% 0.01x 1.08x GBX-44.24 Million
2022 -147.93% -1524.44% 0.05x 2.07x GBX-48.34 Million
2023 -654.61% -1340.20% 0.08x 6.05x GBX-46.30 Million
2023 35.84% 10.88% 0.79x 4.16x GBX4.68 Billion
2024 0.00% -1461.60% 0.29x 0.00x GBX-32.67 Million
2025 0.00% -680.00% 0.49x 0.00x GBX-19.70 Million

Industry Comparison

This section compares Renalytix AI plc's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $26,820,488
  • Average return on equity (ROE) among peers: -6.68%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Renalytix AI plc (RENX) GBX-1.37 Million 20.37% N/A $95.71K
Cambridge Cognition Holdings Plc (COG) $3.36 Million -53.09% 2.88x $201.09K
Craneware Plc (CRW) $32.41 Million 18.56% 0.77x $6.59 Million
Diaceutics PLC (DXRX) $1.01 Million 73.81% 2.40x $1.70 Million
Feedback PLC (FDBK) $1.20 Million -39.29% 0.61x $51.98K
Induction Healthcare Group PLC (INHC) $-2.64 Million 0.00% 0.00x $111.33K
IQ-AI Ltd (IQAI) $590.00K -47.63% 0.17x $24.76K
Kooth plc (KOO) $10.52 Million -6.81% 0.53x $563.19K
Optima Health plc (OPT) $168.12 Million 0.98% 0.30x $2.04 Million

About Renalytix AI plc

LSE:RENX UK Health Information Services
Market Cap
$95.71K
GBX786.63 Million GBX
Market Cap Rank
#30995 Global
#1119 in UK
Share Price
GBX1.80
Change (1 day)
+0.00%
52-Week Range
GBX1.80 - GBX10.75
All Time High
GBX1220.00
Categories
Companies in UK Health Information Services Technology
About

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from … Read more